David Trimnel

Sickle Cell 101 Unveils Its Innovative Approach in Digital Advocacy for a 'Rare' Disorder Through Social Media

Retrieved on: 
Wednesday, February 1, 2023
Disease, Infection, Social media, Hospital, Education, Tissue, Empowerment, Cystic fibrosis, Sickle cell disease, Anti-transglutaminase antibodies, FDA, Degenerative disease, Patient, University, Research, LIGO Scientific Collaboration, Stroke, David Trimnel, Pain, Pharmaceutical industry, Sickle

San Jose, California--(Newsfile Corp. - February 1, 2023) - Sickle Cell 101 , a non-profit organization, is using an innovative approach of digital advocacy to provide education and patient focused research for sickle cell.

Key Points: 
  • San Jose, California--(Newsfile Corp. - February 1, 2023) - Sickle Cell 101 , a non-profit organization, is using an innovative approach of digital advocacy to provide education and patient focused research for sickle cell.
  • With a community that reaches millions on social media spread across 115 countries, Sickle Cell 101 has made a significant impact in promoting awareness of both sickle cell disease and sickle cell trait at the grassroots level through their digital platform, rich in educational and research resources.
  • "Our goal at Sickle Cell 101 is to function as a global platform to educate, engage, and empower an underserved community," says Cassandra Trimnell, Founder and Executive Director of Sickle Cell 101.
  • Sickle Cell 101 continues to seek and transform the outlook and experiences for individuals living with sickle cell disease through education and empowerment and spurring research in this area.